22ND CENTURY GROUP INC (XXII) Stock Overview
USA - NASDAQ:XXII - US90137F5098 - Common Stock
XXII Key Statistics, Chart & Performance
The current stock price of XXII is 1.45 USD. In the past month the price decreased by -11.04%. In the past year, price decreased by -99.53%.
XXII Latest News, Press Relases and Analysis
XXII Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PM | PHILIP MORRIS INTERNATIONAL | 19.72 | 226.89B | ||
| BTI | BRITISH AMERICAN TOB-SP ADR | 10.8 | 111.76B | ||
| MO | ALTRIA GROUP INC | 10.7 | 95.97B | ||
| RLX | RLX TECHNOLOGY INC-ADR | 23.5 | 2.86B | ||
| TPB | TURNING POINT BRANDS INC | 24.05 | 1.62B | ||
| UVV | UNIVERSAL CORP/VA | 12.24 | 1.25B | ||
| ISPR | ISPIRE TECHNOLOGY INC | N/A | 115.13M |
Related stock screener links
About XXII
Company Profile
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. The company is headquartered in Williamsville, New York and currently employs 56 full-time employees. The company went IPO on 2006-10-17. The firm manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The firm's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The firm operates through a single segment named Tobacco. The company is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The company is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
Company Info
22ND CENTURY GROUP INC
8560 Main St Ste 4
Williamsville NEW YORK 14221 US
CEO: James A. Mish
Employees: 56
Phone: 17162701523
22ND CENTURY GROUP INC / XXII FAQ
What does XXII do?
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. The company is headquartered in Williamsville, New York and currently employs 56 full-time employees. The company went IPO on 2006-10-17. The firm manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The firm's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The firm operates through a single segment named Tobacco. The company is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The company is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
Can you provide the latest stock price for 22ND CENTURY GROUP INC?
The current stock price of XXII is 1.45 USD. The price decreased by -9.94% in the last trading session.
What is the dividend status of 22ND CENTURY GROUP INC?
XXII does not pay a dividend.
What is the ChartMill technical and fundamental rating of XXII stock?
XXII has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for 22ND CENTURY GROUP INC?
22ND CENTURY GROUP INC (XXII) operates in the Consumer Staples sector and the Tobacco industry.
What is the next earnings date for XXII stock?
22ND CENTURY GROUP INC (XXII) will report earnings on 2025-11-10.
What is the Short Interest ratio of 22ND CENTURY GROUP INC (XXII) stock?
The outstanding short interest for 22ND CENTURY GROUP INC (XXII) is 6.6% of its float.
XXII Technical Analysis
XXII Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to XXII. While XXII seems to be doing ok healthwise, there are quite some concerns on its profitability.
XXII Financial Highlights
Over the last trailing twelve months XXII reported a non-GAAP Earnings per Share(EPS) of -2190.45. The EPS increased by 98.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -99.71% | ||
| ROE | -396.39% | ||
| Debt/Equity | 0 |
XXII Forecast & Estimates
7 analysts have analysed XXII and the average price target is 5.1 USD. This implies a price increase of 251.72% is expected in the next year compared to the current price of 1.45.
For the next year, analysts expect an EPS growth of 93.77% and a revenue growth -43.66% for XXII